Newsroom

Press Releases

image of a mouse brain
Inscopix Inc. and SRI International to Collaborate on Brain Imaging R&D
October 11, 2012

Researchers from SRI’s Center for Neuroscience and Metabolic Diseases will use Inscopix’s nVista HD imaging system to gain a better understanding of normal brain function and the dysfunctions of neural circuitry that underlie neurological and neuropsychiatric disorders.

Topics: Addiction Research Behavioral Health Medical Imaging Neurodegenerative Diseases Neuroscience
building in Michigan
SRI International to Open Clinical Trial Facility, Michigan’s First Center of Innovation
September 27, 2012

The Michigan Strategic Fund approved the Center of Innovation designation and $5 million in initial funding for SRI Biosciences to open a Phase 1 clinical trial facility that will address unmet medical needs.

Topics: Biomarkers Clinical Laboratory Services Pharmaceutical R+D
Joseph Rogers
Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
August 28, 2012

In his career, Rogers has focused on age-related neurologic diseases. He is best known for showing that inflammatory responses occur in almost all major age-related brain disorders and cause substantial damage, with his seminal paper in the area receiving nearly 1,200 citations to date.

Topics: Addiction Research Aging Research Behavioral Health Biomarkers Human Sleep Metabolic Diseases Neurodegenerative Diseases Neuroscience
tiger mosquito close-up on human arm
Common U.S. Mosquitoes Can Transmit Disease-Causing Virus from Asia
August 22, 2012

Researchers from SRI International have demonstrated that mosquitoes from Virginia and Georgia can transmit a virus called Chikungunya (CHIKV), which has infected more than 2 million people in Asia, Africa, and parts of Europe since 2005.

Topics: Disease Focus Areas Infectious Diseases
microscopic view of the HIV virus
SRI International Researchers Developing Bioadhesive Gel to Protect Women from HIV and HSV Infections
July 24, 2012

Researchers are developing and testing a topical microbicide gel for drug delivery. The innovative formulation will be a combination therapy against human immunodeficiency virus (HIV) and herpes simplex virus type 2 (HSV-2) infections in women.

Topics: Alternative Drug Delivery Systems Drug Formulation Development Drug Pipeline Infectious Diseases Pharmaceutical R+D Pharmaceutical Sciences: Analytical Chemistry Pharmaceutical Sciences: Stability Studies Preclinical Drug Development
Researchers Developing New Multiple Sclerosis Drug That Can Be Taken Orally
July 10, 2012

Researchers at SRI are developing a new Multiple Sclerosis drug that can be taken by mouth. It will be more convenient than current treatments, which require frequent hospital visits for injections or intravenous infusions.

Topics: Alternative Drug Delivery Systems Drug Formulation Development Drug Pipeline Immunology + Inflammation Medicinal Chemistry Pharmaceutical R+D Pharmaceutical Sciences: Stability Studies Preclinical Drug Development
Rathnam Chaguturu of SRI International
Rathnam Chaguturu Joins SRI's Center for Advanced Drug Research as Senior Director of Exploratory Research
January 25, 2012

Rathnam Chaguturu, Ph.D., has joined SRI International's Center for Advanced Drug Research as senior director of Exploratory Research.

Topics: Disease Focus Areas Drug Discovery Infectious Diseases Pharmaceutical R+D Pharmaceutical Sciences: Analytical Chemistry Proteomics

SRI In the News

Gel Developed in Menlo Park Could Help Prevent HIV, HSV-2
KGO-TV ABC 7  |  October 3, 2012

SRI Biosciences is developing a long-lasting, two-part microbicide gel to protect women from HIV and HSV infections—and the delivery system puts the technology in the hands of women themselves.

Topics: Immunology + Inflammation
Michigan Strategic Fund to approve $5M for testing lab in Plymouth Township
Crain's Detroit Business  |  September 27, 2012

The article reports that the initial funding from The Michigan Strategic Fund would go to the Biosciences division of SRI International.

SRI International Research: Mosquitoes Common in the U.S. Can Transmit Disease-Causing Virus Endemic to Asia
Info Tech  |  August 28, 2012

This article reports that “new research from SRI International finds that mosquitoes commonly found in the United States can be infected with a disease-causing virus from Asia.”

Topics: Disease Focus Areas Infectious Diseases
Mosquitoes in the U.S. Can Be Infected with Chikungunya Virus from Asia
News-Medical.net  |  August 23, 2012

This press release reports that new research from SRI International finds that mosquitoes commonly found in the United States can be infected with a disease-causing virus from Asia.

Topics: Disease Focus Areas Infectious Diseases
Mosquitoes Appear to be Increasing Health Threat
Consumer Affairs  |  August 23, 2012

According to this article, in addition to West Nile Virus mosquitoes can also carry a disease-causing virus from Asia. “In laboratory experiments, researchers at SRI International demonstrated that mosquitoes from Virginia and Georgia can transmit a virus called Chikungunya (CHIKV)..."

Topics: Disease Focus Areas Infectious Diseases
SRI to Develop Bioadhesive HIV and HSV Formulation
in-Pharma  |  July 30, 2012

According to this article, “Researchers at SRI International say a bioadhesive-based platform delivery could help slow the spread of HIV and HSV in Africa.”

Trials Enlist Vaginal Gel and Ring in Fight against HIV
Fierce Drug Delivery  |  July 25, 2012

This article reports that researchers at SRI International have received a grant from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a gel that could cut the levels of infection from life-threatening viruses such as HIV and HSV-2 (herpes simplex virus type 2).

SRI Wins Grants to Develop Technologies
The Almanac  |  July 18, 2012

This article reports that SRI International recently received two federal grants, “one to develop technology to use natural gas in vehicles, and the other to develop an oral therapy for multiple sclerosis."

Topics: Drug Discovery Energy + Sustainability
Wanted: Specially Designed Tools For Pediatric Surgery
National Public Radio (NPR)  |  February 20, 2012

This radio and online story describes how SRI engineers are working with surgeons to solve challenging problems in medical product design.

Surgeons Seek Kid-Sized Tools for the Operating Room
KQED  |  January 27, 2012

This radio story and online article reports on how SRI engineers are collaborating with surgeons to create improved medical tools that are more appropriately sized for pediatric use.

Events

ICAAC event logo
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting
San Francisco, CA  |  September 9, 2012

SRI Biosciences will exhibit.

Topics: Basic Cancer Research Cancer Drug Discovery
pills
American Association of Pharmaceutical Scientists (AAPS) Annual Meeting
Chicago, IL  |  October 14, 2012

SRI Biosciences will exhibit.

Topics: Pharmaceutical R+D Preclinical Drug Development
Rajeev Vaidyanathan
Entomological Society of America 2012 Annual Meeting
Knoxville, TN  |  November 11, 2012

SRI's Rajeev Vaidyanathan will present "Transcriptional Silencing of a Phosphotransferase Kills Mosquito Larvae".

Topics: Infectious Diseases
scientist writing chemical symbols
American Society of Tropical Medicine and Hygiene (ASTMH) Annual Meeting
Atlanta, GA  |  November 11, 2012

SRI Biosciences will exhibit.

Topics: Infectious Diseases Pharmaceutical R+D Proteomics
CACO Pharmaceutical & BioScience Society - Biomarkers Seminar
Foster City, CA  |  December 7, 2012

SRI Biosciences will exhibit.

Topics: Biomarkers

Podcasts

Kenneth Gollob
Early Diagnosis and Treatment of Infectious Tropical Diseases
May 4, 2012

Researchers are developing novel therapies, diagnostics and biomarkers in the fight against infectious tropical diseases that affect millions of people worldwide, primarily those living in poverty.

Topics: Biomarkers Disease Focus Areas Drug Discovery Infectious Diseases Vaccine Development
Peter Madrid
Faster Infectious Disease Treatment - A Potential New Drug Target
January 19, 2012

In this podcast, Peter Madrid, a program director in SRI's Biosciences Division, discusses the latest SRI research on a new drug target that may potentially reduce infectious disease treatment time.

Topics: Disease Focus Areas Drug Discovery Infectious Diseases Pharmaceutical R+D
Gita Shankar, director of formulations R&D, SRI Biosciences
Oral Drug Formulation: Helping Patients and Reducing Costs
January 5, 2012

In this podcast, Gita Shankar, director of formulations R&D, in SRI's Biosciences Division, explains how drugs taken by mouth offer many advantages to patients.

Topics: Drug Formulation Development Pharmaceutical R+D

Filter